MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611025661 A) filed by Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, on March 4, for 'nanostructured phytosomal transdermal gel composition and process for rheumatoid arthritis treatment.'
Inventor(s) include Dr. Sumita Singh; Dr. Kunal Arora; Mr. Nishant Gaurav; and Dr. Vaishali M. Patil.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a nanostructured phytosomal transdermal gel composition and process thereof for the treatment of rheumatoid arthritis. The composition comprises a standardized hydro-alcoholic extract of Ricinus communis leaf complexed with a phospholipid component, preferably phosphatidylcholine, in a defined molar ratio to form a phytosomal complex. The phytosomal nanocarriers possess a particle size in the nanometer range and are incorporated into a pharmaceutically acceptable polymeric gel matrix comprising a gelling agent selected from Carbopol 934 or hydroxypropyl methylcellulose. The formulation enhances lipid compatibility and dermal permeation of bioactive phytoconstituents, enabling sustained localized anti-inflammatory delivery at inflamed joint sites while minimizing systemic exposure."
Disclaimer: Curated by HT Syndication.
